Barring investment in ESG initiatives is not just counterproductive and dangerous — it’s fiscally foolish.
Usually, the number of times a major policy issue receives bipartisan support is between none and zero. But in this case, each party has an axe to grind.
New Q3 2022 data from PitchBook on venture capital aggregates in the U.S. make it a bit hard to square reality with the leading narrative.
Enterprise startups are increasingly turning their attention to landing the federal government as a customer -- and VCs are all-in.
The answer to whether Elon Musk should abandon the Tesla CEO post probably depends on your view of the company's prototype robot, Optimus.
Crypto markets grew the most in the Middle East and North Africa in 2022 due to economic incentives and regulation.
Here's what happens if you force a company to accept your bid, and then later have to close the deal after the stock market has sold off.
Ahead of its IPO, Mobileye notes it has benefited from its first-mover advantage but now faces a proliferating number of rivals worldwide.
Optimization is the next big thing in cloud management, because organizations will continue to look for ways to cut costs, and optimization tooling offers a clear solution.
Despite many VCs saying they were going to focus on startups with good underlying business fundamentals, they still favor growth.
Crypto "losses” from hacks and fraud continued to decline in the third quarter, Immunefi’s Crypto Losses Q3 report shows.
The European Space Agency and Airbus teamed up with New Zealand-based startup Emrod to demonstrate a wireless power transfer system last week.
Learning is something we all do from our earliest days to our final years, and the breadth of edtech is beginning to reflect this truth, and so is the startup and investment landscape.
Let's chat through the Naver-Poshmark deal's numbers and consider how the late-2022 M&A market differs from that of mid-2021.
Rather than an unfairly targeted outlier, count Kim Kardashian as the first of many celebrities who should start facing the consequences of their actions.
Liquid Death is more than simply bougie water. It comes with built-in liquidity, ensuring that its investors won't be parched on the deal.
With public stock valuations way down, it's surprising we aren't seeing more aggressive M&A activity from acquisitive companies and private equity alike.
If unicorns are not able to raise as much this year as they did in, say, 2019, how many of the billion-dollar-plus startups are going to survive?
Investors are betting large amounts of money on fusion. Here's why they're so confident the technology has banished the ghosts of its past.
Form Bio was incubated within Colossal Biosciences and now is hoping to bring its workflow systems to other computational biology companies.